TABLE 3.

Joinpoint analysis for lung cancer mortality of females in 25 EU countries, UK and USA for years 2000 to 2017, where data available

Country	Trend 1			Trend 2			Trend 3			Trend 4
	Years	EAPC	95% CI of EAPC	Years	EAPC	95% CI of EAPC	Years	EAPC	95% CI of EAPC	Years	EAPC	95% CI of EAPC
USA#	2000–2003	0.2	−0.7–1	2003–2009	−1.1	−1.5– −0.7	2009–2014	−2.2	−2.7– −1.6	2014–2017	−4.2	−5– −3.4
Cyprus	2004–2016		−2–5.4
Austria	2000–2017	1.8	1.3–2.3
Belgium	2000–2011	4.2	3.5–4.8	2011–2016	−0.1	−2.1–1.9
Bulgaria	2000–2015	2.2	1.5–2.9
Croatia	2000–2016	2.4	1.8–3
Czech Republic	2000–2017	0.7	0.4–1.1
Denmark	2000–2005	1.7	−0.4–3.9	2005–2015	−0.9	−1.7– −0.2
Estonia	2000–2016	2	1.2–2.8
Finland	2000–2016	1.9	1.6–2.3
France	2000–2005	6.6	5.1–8.1	2005–2014	2.8	2.2–3.4
Germany	2000–2011	2.9	2.6–3.1	2011–2016	1	0.2–1.8
Greece	2000–2005	0.1	−1.5–1.7	2005–2016	3.7	3.2–4.2
Hungary	2000–2017	2.1	1.7–2.5
Ireland	2000–2006	1.9	−0.1–3.8	2006–2015	−0.4	−1.5–0.6
Italy	2000–2015	1.9	1.8–2.1
Latvia	2000–2015	1.2	0.1–2.4
Lithuania	2000–2017	1.1	0.3–1.9
Netherlands	2000–2007	4.2	3.4–5	2007–2016	0.8	0.3–1.4
Poland	2000–2016	2.4	2.1–2.7
Portugal	2000–2016	2.6	2.1–3.1
Romania	2000–2017	2.3	2–2.6
Slovakia	2000–2014	2.4	1.7–3.1
Slovenia	2000–2015	2.5	2–3.1
Spain	2000–2015	4.4	4.1–4.7
Sweden	2000–2005	3.5	1.2–5.9	2005–2016	−0.5	−1.2–0.2
UK	2001–2008	1.7	1.1–2.3	2008–2016	−0.7	−1.2– −0.2

^#: USA data are standardised based on the US population. CDC WONDER database is used for data collection in the USA.